trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Adenocarcinoma, Follicular D018263 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Park JW et al. Microbial transformation of trichostatin A to 2,3-dihydrotrichostatin A. 2011 J. Nat. Prod. pmid:21504214
Eskeland R et al. Histone acetylation and the maintenance of chromatin compaction by Polycomb repressive complexes. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21502416
Kretzner L et al. Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. 2011 Cancer Res. pmid:21502403
Zelko IN et al. Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21493784
Chen MY et al. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. 2011 Cancer pmid:21491416
Hattori N et al. Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas. 2011 Cancer Sci. pmid:21489049
Wang Y et al. The effects of 5-aza-2'- deoxycytidine and trichostatin A on gene expression and DNA methylation status in cloned bovine blastocysts. 2011 Cell Reprogram pmid:21486115
Cui XS et al. Trichostatin A modulates apoptotic-related gene expression and improves embryo viability in cloned bovine embryos. 2011 Cell Reprogram pmid:21473694
Yang J et al. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21473137
Nagamine MK et al. In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor. 2011 Vet. Res. Commun. pmid:21472452
Zhang CZ et al. Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment. 2011 Apoptosis pmid:21468663
Kimura T et al. Chromium (VI) inhibits mouse metallothionein-I gene transcription by modifying the transcription potential of the co-activator p300. 2011 J Toxicol Sci pmid:21467744
Pang M et al. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. 2011 J. Cell. Biochem. pmid:21465537
Law AY et al. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29. 2011 J. Cell. Biochem. pmid:21465530
Miller L et al. Histone deacetylase 1 (HDAC1) participates in the down-regulation of corticotropin releasing hormone gene (crh) expression. 2011 Physiol. Behav. pmid:21463644
Belakavadi M et al. Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. 2011 Mol. Cell. Endocrinol. pmid:21458529
Min XJ et al. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells. 2011 Exp. Biol. Med. (Maywood) pmid:21454376
Sun JY et al. Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemia. 2011 Clin Lymphoma Myeloma Leuk pmid:21454220
Agudelo M et al. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). 2011 Alcohol. Clin. Exp. Res. pmid:21447001
Briggs B et al. Photosensitization by iodinated DNA minor groove binding ligands: Evaluation of DNA double-strand break induction and repair. 2011 J. Photochem. Photobiol. B, Biol. pmid:21440453
Kadowaki M et al. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines. 2012 Int. J. Cancer pmid:21437897
Jergil M et al. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells. 2011 Toxicol. Sci. pmid:21427059
WEI Q et al. [Trichostatin A inhibits the activation of CD(4)(+) T cells by suppressing CD(28) expression in mice]. 2011 Nan Fang Yi Ke Da Xue Xue Bao pmid:21421475
Zhang Y et al. ERK1/2 activation plays important roles in the opposite effects of Trichostatin A in non-cancer and cancer cells. 2011 Toxicon pmid:21419152
Kawasaki H et al. Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. 2011 PLoS ONE pmid:21407806
Zhang J et al. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. 2011 Endocrinology pmid:21406501
Diao JS et al. Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. 2011 Arch. Dermatol. Res. pmid:21400246
Seitz V et al. Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation. 2011 Haematologica pmid:21393330
Fan T et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. 2011 Mol. Cancer Res. pmid:21383005
Jang ER et al. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines. 2011 Mol. Cell. Biochem. pmid:21380726
Hsu YF et al. p53 in trichostatin A induced C6 glioma cell death. 2011 Biochim. Biophys. Acta pmid:21376104
Zhu QY et al. C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo. 2011 Cell Death Dis pmid:21368888
Dong X et al. Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. 2011 Endocr. Relat. Cancer pmid:21367844
Kim YJ et al. Comparison of potency between histone deacetylase inhibitors trichostatin A and valproic acid on enhancing in vitro development of porcine somatic cell nuclear transfer embryos. 2011 In Vitro Cell. Dev. Biol. Anim. pmid:21359816
Furuta K et al. The CKH2/PKL chromatin remodeling factor negatively regulates cytokinin responses in Arabidopsis calli. 2011 Plant Cell Physiol. pmid:21357580
Chaurasia P et al. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. 2011 Blood pmid:21355088
Zhang F et al. Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis. 2011 PLoS ONE pmid:21346816
Fang Y et al. Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341. 2011 Cancer Invest. pmid:21345073
Chen YT et al. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy. 2011 Spine pmid:21343850
Fan Y et al. Derivation of cloned human blastocysts by histone deacetylase inhibitor treatment after somatic cell nuclear transfer with β-thalassemia fibroblasts. 2011 Stem Cells Dev. pmid:21322785
Shi G et al. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells. 2011 J. Cell. Physiol. pmid:21321941
Patel T et al. Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice. 2011 Immunol. Cell Biol. pmid:21321581
Yang H et al. Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors. 2011 Hepatology pmid:21319187
Meli M et al. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells. 2011 Int. J. Oncol. pmid:21318222
Hizaki K et al. Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. 2011 Mod. Pathol. pmid:21317879
Qian Y et al. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation. 2011 J. Biol. Chem. pmid:21317427
Saiyed ZM et al. HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). 2011 Neurochem. Int. pmid:21315782
Li S et al. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. 2011 Mol. Cancer pmid:21314984
Li Z et al. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines. 2011 Cell Biol. Int. pmid:21314642
Biermann J et al. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. 2011 Mol. Vis. pmid:21311741
Turovets N et al. Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin A pretreatment. 2011 Differentiation pmid:21306817
Zhou X et al. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice. 2011 J. Clin. Immunol. pmid:21305388
Furumai R et al. Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment. 2011 Cancer Sci. pmid:21299717
Bogaard HJ et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. 2011 Am. J. Respir. Crit. Care Med. pmid:21297075
Puppin C et al. In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription. 2011 Cell Oncol (Dordr) pmid:21290209
MacTavish H et al. Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. 2010 PLoS ONE pmid:21283510
Nakamura J et al. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer. 2011 Am. J. Pathol. pmid:21281785
Ishiguro K et al. Cutting edge: tubulin α functions as an adaptor in NFAT-importin β interaction. 2011 J. Immunol. pmid:21278340
Cai HH et al. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. 2011 HBPD INT pmid:21269942
Jee BC et al. Effect of trichostatin A on fertilization and embryo development during extended culture of mouse oocyte. 2012 Zygote pmid:21269543
Pianta A et al. Nucleophosmin delocalization in thyroid tumour cells. 2011 Endocr. Pathol. pmid:21258971
Choi E et al. Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21256006
Yoon CY et al. The histone deacetylase inhibitor trichostatin A synergistically resensitizes a cisplatin resistant human bladder cancer cell line. 2011 J. Urol. pmid:21255805
Lee SC et al. HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter. 2011 J. Biomed. Biotechnol. pmid:21253530
Zou CF et al. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. 2011 BMC Cancer pmid:21244707
Hai T et al. Pluripotency maintenance in mouse somatic cell nuclear transfer embryos and its improvement by treatment with the histone deacetylase inhibitor TSA. 2011 Cell Reprogram pmid:21241188
Lei L et al. Epigenetic repression of SATB1 by polycomb group protein EZH2 in epithelial cells. 2010 Chin. Med. Sci. J. pmid:21232178
Mizuno S et al. Inhibition of histone deacetylase causes emphysema. 2011 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:21224215
Nandakumar V et al. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. 2011 Carcinogenesis pmid:21209038
Farinas B and Mas P Functional implication of the MYB transcription factor RVE8/LCL5 in the circadian control of histone acetylation. 2011 Plant J. pmid:21205033
Erb TM et al. Paracrine and epigenetic control of trophectoderm differentiation from human embryonic stem cells: the role of bone morphogenic protein 4 and histone deacetylases. 2011 Stem Cells Dev. pmid:21204619
Kitano A et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. 2010 Mol. Vis. pmid:21203344
Liao M et al. Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription. 2011 J. Biol. Chem. pmid:21193408
Mitmaker EJ et al. Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. 2011 Surgery pmid:21193210
Kang H and Roh S Extended exposure to trichostatin A after activation alters the expression of genes important for early development in nuclear transfer murine embryos. 2011 J. Vet. Med. Sci. pmid:21187677
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Yin H et al. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells. 2011 Mol. Biol. Rep. pmid:21181272
Spin JM et al. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. 2010 PLoS ONE pmid:21179216
Trtková K et al. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. 2010 Cancer Biomark pmid:21178266
Tsai PF et al. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. 2011 J. Virol. pmid:21159880
Puppin C et al. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. 2011 Oncol. Rep. pmid:21152868
Shiratsuki S et al. Trichostatin A-treated eight-cell bovine embryos had increased histone acetylation and gene expression, with increased cell numbers at the blastocyst stage. 2011 Theriogenology pmid:21144563
Wang YS et al. Production of cloned calves by combination treatment of both donor cells and early cloned embryos with 5-aza-2/-deoxycytidine and trichostatin A. 2011 Theriogenology pmid:21144561
Gao A et al. Epigenetic modification involved in benzene-induced apoptosis through regulating apoptosis-related genes expression. 2011 Cell Biol. Int. pmid:21143203
Ma AN et al. Histone deacetylation directs DNA methylation in survivin gene silencing. 2011 Biochem. Biophys. Res. Commun. pmid:21130077
Vrzal R et al. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia? 2011 Toxicol. Lett. pmid:21115105
Pabba C et al. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21109435
Bayles R et al. Histone modifications regulate the norepinephrine transporter gene. 2010 Cell Cycle pmid:21088495
Chakravarty G et al. Cytoplasmic compartmentalization of SOX9 abrogates the growth arrest response of breast cancer cells that can be rescued by trichostatin A treatment. 2011 Cancer Biol. Ther. pmid:21084857
Muralidhar SA et al. Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. 2011 J. Biol. Chem. pmid:21078662
Peidis P et al. HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. 2010 Aging (Albany NY) pmid:21076179
Wang JP et al. Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression. 2011 Differentiation pmid:21074928
Auzzas L et al. Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity. 2010 J. Med. Chem. pmid:21073160
Nicodeme E et al. Suppression of inflammation by a synthetic histone mimic. 2010 Nature pmid:21068722
Fu J et al. Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. 2010 Bioorg. Med. Chem. pmid:21067930
Marrazzo A et al. Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells. 2011 Eur J Med Chem pmid:21055848
Giles KE et al. Chromatin boundaries, insulators, and long-range interactions in the nucleus. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21047907
Coleman SL et al. Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages. 2011 Eur J Nutr pmid:21046125
Su Y et al. Human RecQL4 helicase plays critical roles in prostate carcinogenesis. 2010 Cancer Res. pmid:21045146
Oyer JA et al. Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation. 2011 Mutat. Res. pmid:21035468